2d
MedPage Today on MSNDeciding Whether Multiple Sclerosis Treatment Should Be DiscontinuedObservational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...
March is Multiple Sclerosis awareness month. M.S. is a disease of the brain and spinal cord that affects almost a million ...
Dimika V. Cavalier shares details of her long MS diagnosis journey and the eventual acceptance of her new normal.
Multiple Sclerosis, also known as M.S. is a chronic autoimmune disease that affects the brain and spinal cord. While the way ...
3d
Live Science on MSNIn a 1st, trial finds vitamin D supplements may slow multiple sclerosis. But questions remain.A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...
Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in ...
A decision on tolebrutinib for treating MS is now set for Sept. 28, after the FDA granted priority review to its approval ...
Sponsor: OhioHealth The latest episode of The Wellness Conversation – an OhioHealth Podcast, delves into the complexities of ...
Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis If approved, tolebrutinib would be the first and only brain-penetrant BTK inhibitor to ...
Tolebrutinib is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory ...
Christina Applegate revealed she's been hospitalized more than 30 times in three years since being diagnosed with multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results